Skip to main content
. 2024 Feb 12;130(8):1316–1323. doi: 10.1038/s41416-023-02569-4

Fig. 3. BM-OS.

Fig. 3

Looking at overall survival from brain metastasis (BM) resection (BM-OS), no correlation was demonstrated with TMB (Tumor Mutation Burden) (a), HER2 amplification (HER2+) (b) and KRAS mutations (c) on BM. Instead, statistically significant advantage was observed in case of TILS ≥ 1.6 on BM (d).